GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial

Neoadjuvant chemotherapy (NCT) is a standard care for esophageal squamous cell carcinoma (ESCC), but the efficacy is unsatisfactory. Cancer stem cells (CSCs) play key roles in chemotherapy resistance. Gene amplified in squamous cell carcinoma 1 (GASC1) is a neoteric gene in stemness maintaining of E...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Ruinuo, Mi, Youjia, Yuan, Xiang, Kong, Dejiu, Li, Wanying, Li, Ruonan, Wang, Bingbing, Zhu, Yafei, Kong, Jinyu, Ma, Zhikun, Li, Na, Mi, Qiangjian, Gao, Shegan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204099/
https://www.ncbi.nlm.nih.gov/pubmed/32411232
http://dx.doi.org/10.1155/2020/1607860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204099/
https://www.ncbi.nlm.nih.gov/pubmed/32411232
http://dx.doi.org/10.1155/2020/1607860

Ejemplares similares